News
FDA expands Mounjaro approval for heart attack and stroke prevention
Summary by The Waco Editorial Desk · Byline on the source page: Scripps News Group , as published by KXXV (ABC 25) News
· August 31, 2026
· 1 min read
Photo: KXXV (ABC 25) News · view original
Story provenance No corrections
Summary created by The Waco Editorial Desk — automated, rule-governed Byline on source page Scripps News Group, as published by KXXV (ABC 25) News Original story Read at the source Source published Aug 31, 2026 Indexed here Aug 31, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key points A company representative discussed the medication's potential to lower the risk of heart disease, a leading cause of death for people with type 2 diabetes. High-risk adults with type 2 diabetes may benefit from an expanded use of a certain medication.
High-risk adults with type 2 diabetes may benefit from an expanded use of a certain medication. The drug, produced by Eli Lilly, has been approved to help prevent heart attacks and strokes. This development builds on the medication's existing uses.
Further information is available about the medication's track record and testing. A company representative discussed the medication's potential to lower the risk of heart disease, a leading cause of death for people with type 2 diabetes.
Details about the medication and its uses can be found through related stories and updates from the source.
More News Today’s briefing Local events
Why this story is here
KXXV (ABC 25) News reported and published this story. The Waco selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
About this story
As published by KXXV (ABC 25) News . The Waco selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KXXV (ABC 25) News . Have a tip or correction? Contact the editor .
Category: News ·
Published: August 31, 2026 ·
Source: KXXV (ABC 25) News ·
Reading time: 1 min
Frequently asked about this story
What is this story about? High-risk adults with type 2 diabetes may benefit from an expanded use of a certain medication. The drug, produced by Eli Lilly, has been approved to help prevent heart attacks and strokes. This…
When was this published? This article was first published on August 31, 2026 by KXXV (ABC 25) News and curated for The Waco readers.
Who reported this story? This story was reported by Scripps News Group at KXXV (ABC 25) News. To learn more about how The Waco selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The Waco, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter